Genetics In-Vitro In-Vivo 
Medical Xpress
MAY 16, 2023
They study gene variation and mutations that cause rare genetic diseases. A mutation is a permanent change in the genetic material. That was the case when Thilini Gamage was to carry out one of the studies in her doctoral work with Professor Eirik Frengen at the Institute of Clinical Medicine, University of Oslo.
Pharmaceutical Technology
OCTOBER 5, 2022
Autologous CAR-T therapy does not easily lend itself to treating CLL, as it relies on extracting functional T-cells from the patient’s blood and genetically modifying them in vitro. From a clinical perspective, CAR-T therapy may not be appropriate for patients who are typically eligible for cell therapies.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
NOVEMBER 4, 2022
The staff in the US from the acquired business will be retained by Reaction to set up its presence in Hershey, which comprises in vitro and in vivo expertise. The staff in the US from the acquired business will be retained by Reaction to set up its presence in Hershey, which comprises in vitro and in vivo expertise.
The Pharma Data
MAY 3, 2021
The division served as the rapporteur in the effort to update the International Council for Harmonisation (ICH) E14 and S7B guidelines on the clinical and nonclinical evaluation of QT/QTc interval prolongation and proarrhythmic potential and leads research for the Comprehensive in vitro Proarrhythmia Assay initiative.
The Pharma Data
NOVEMBER 17, 2020
Dr. Anderson has been an early adopter in blastocyst embryo transfer, cryopreservation and pioneered blastocyst biopsy with and without laser technology for genetic testing. . SARASOTA, Fla. , 18, 2020 /PRNewswire/ — INVO Bioscience , Inc. Drs. and across the world.
Delveinsight
JANUARY 18, 2021
Angelman syndrome (AS) is a complex genetic rare disorder that affects the nervous system. Preclinical studies undertaken to evaluate the drug have shown that GTX-102 activates the paternal copy of the UBE3A gene in neurons in vitro, and can ease certain disease symptoms in a mouse model of Angelman syndrome.
XTalks
OCTOBER 1, 2020
Leaving academia for industry is a route that academic scientists and professors did not traditionally pursue in the past due to perceived differences in skillsets, experiences and even associated stigmas. However, this has since changed, and now, transitioning between academia and industry has become more commonplace. Key Moments.
Expert insights. Personalized for you.
98 
Let's personalize your content